Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

• Status: Not yet recruiting
• Trial end date: 2020-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigator study evaluate the effect of different lipid lowering agents on the progression of diabetic retinopathy and other reduction of cardiovascular risk of diabetic patients

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alaa Hassan ElBaz
• Treatments: Fenofibrate; Hypolipidemic Agents; Simvastatin

Criteria

Inclusion Criteria:

• type 2diabetes

• Non proliferative diabetic retinopathy

Exclusion Criteria:

• Uncontrolled glycemic level

• proliferative diabetic retinopathy